$9.99
-$0.18
(-1.77%)
Quote as of 4:00 PM EST on 02/09/12
Progenics Pharmaceuticals, Inc...
NASDAQ:PGNX
|
$9.99
-$0.18
(-1.77%)
|
|
| Today's Open | $10.17 |
|---|---|
| Previous Close | $10.17 |
| Daily Range | $9.74 - $10.17 |
| 52-Week Range | $4.50 - $10.50 |
| Market Cap | $337.29M |
| P/E Ratio | 169.50 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 113,751 |
| Average Daily Volume | 135,299 |
| Current FY EPS | $0.34 |
PGNX Information
| Description |
|---|
| A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Salix Scores with Oral Relistor - Analyst Blog
2-Star Stocks Poised to Plunge: Progenics?
US Stock Futures: HOT STOCKS TO WATCH
US Stock Futures: HOT STOCKS TO WATCH
Salix Pharmaceuticals Shares Popped: What You Need to Know
Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies
Don't Get Too Worked Up Over InterMune's Earnings
FDA Insider Trading: Time for an Overhaul?
Paul Tudor Jones' Favorite Long Positions
